[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH

被引：209

作者：

Afshar-Oromieh, A. ^{[1
]}

Haberkorn, U. ^{[1
]}

Eder, M. ^{[2
]}

Eisenhut, M. ^{[2
]}

Zechmann, C. M. ^{[1
]}

机构：

[1] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany

[2] German Canc Res Ctr, Dept Radiopharmaceut Chem, D-6900 Heidelberg, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 06期

关键词：

MEMBRANE ANTIGEN PSMA;

D O I：

10.1007/s00259-012-2069-0

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：1085 / 1086

页数：2

共 5 条

[1]

Chang SS, 1999, CLIN CANCER RES, V5, P2674

[2]

Chang SS, 1999, CANCER RES, V59, P3192

[3]

Eder M, 2011, BIOCONJUG CHEM

[4] Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer [J].

Ghosh, A ;

Heston, WDW .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (03) :528-539

[5] Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer [J].

Hillier, Shawn M. ;

Maresca, Kevin P. ;

Femia, Frank J. ;

Marquis, John C. ;

Foss, Catherine A. ;

Nguyen, Nghi ;

Zimmerman, Craig N. ;

Barrett, John A. ;

Eckelman, William C. ;

Pomper, Martin G. ;

Joyal, John L. ;

Babich, John W. .

CANCER RESEARCH, 2009, 69 (17) :6932-6940

← 1 →